Full Press Release Details
Precipio Announces Participation Details
for Upcoming Shareholder Conference Call
NEW HAVEN, CT, (April 26, 2018) - Specialty diagnostics
company Precipio, Inc. (NASDAQ: PRPO), provides
details of its previously announced upcoming
shareholder conference call scheduled for Monday April 30, 2018 at 4:30PM EST, where management will provide an extensive strategic
business update and will respond to questions submitted in advance via email.
Investors wishing to
submit questions for management to address during the call may email them to investors@precipiodx.com.
To listen to the call
by phone, interested parties within the U.S. should call 1-877-317-6789; International callers should call 1-412-317-6789.
Callers are asked to request
the Precipio conference call.
An audio replay of the
call will be available approximately 24 hours after the call and may be accessed via Precipio's
Precipio has built a platform designed to eradicate the problem
of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality
diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions
specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard's Dana-Farber
Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information,
please visit www.precipiodx.com.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking
statements," within the meaning of federal securities laws, including statements related to ICP technology, including financial
projections related thereto and potential market opportunity, plans and prospects and other statements containing the words "anticipate,"
"intend," "may," "plan," "predict," "will," "would," "could,"
"should," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. The Company's actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results
or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company's
Annual Report on Form 10-K for the year ended December 31, 2017, the Company's prior filings and from time to time in the
Company's subsequent filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties
may cause the actual results, events and performance to differ materially from those referred to in such statements. All information
in this press release is as of the date of the release and the Company does not undertake any duty to update this information,
including any forward-looking statements, unless required by law.